These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33364828)

  • 1. Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery.
    Zheng C; Feng X; Zheng J; Yan Q; Hu X; Feng H; Deng Z; Liao Q; Wang J; Li Y
    Cancer Manag Res; 2020; 12():12791-12799. PubMed ID: 33364828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P; Ma G; Liu Y; Ke B; Liu HM; Liang H; Zhang RP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):54-62. PubMed ID: 38262901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study.
    Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W
    Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Primary Tumor Resection on Survival of Patients With Metastatic Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Analysis.
    Chen J; Jia X; Chen H; Cai J; Chen L
    Cancer Control; 2023; 30():10732748231208313. PubMed ID: 37851478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y; Liu D; Zeng D; Chen C
    J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
    von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
    J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prognosis in patients with adenocarcinoma of esophagogastric junction with lymph node metastasis of Siewert II/III.
    Zheng Z; Shang Y; Xu R; Zhang H; Yin J; Zhang J; Zhang Z
    Int J Clin Exp Pathol; 2020; 13(5):1262-1269. PubMed ID: 32509102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
    Katz MD; Serrano MF; Humphrey PA; Grubb RL; Skolarus TA; Gao F; Kibel AS
    Urol Oncol; 2011; 29(6):738-44. PubMed ID: 19914106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
    BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
    Front Oncol; 2021; 11():748694. PubMed ID: 34926257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.
    Chen K; Deng X; Yang Z; Yu D; Zhang X; Li W; Xie D; He Z; Cheng D
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):491-497. PubMed ID: 32324423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of survival and prognosis of Siewert Ⅱ/Ⅲ esophagogastric junction adenocarcinoma patients with non-operative acute upper gastrointestinal hemorrhage].
    Tian L; Yu L
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1881-1885. PubMed ID: 32575932
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.
    Feng Y; Jiang Y; Zhao Q; Liu J; Zhang H; Chen Q
    BMC Surg; 2020 Nov; 20(1):302. PubMed ID: 33256690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.